Optimizing Generative AI in Clinical Operations through Focus, Restraint, and Maximized Validation

White paper

Considerations for the responsible use of generative AI to serve the interests of medical research and patient health

Generative artificial intelligence (GenAI) has the potential to have a seismic impact on human healthcare – if used in a considered and careful manner.

Explore the power of GenAI’s use in clinical trials to understand both its risks and its rewards. Learn more about creating a workable, focused framework around GenAI for the benefit of both patients and science.

Read your free white paper to discover:

Why “slow and steady wins the race” when applying focus, guardrails and restraint in GenAI
How to define success: the guiding principles of GenAI
Which 6 key areas of opportunity within clinical trials can benefit most from GenAI
Where and how to implement GenAI solutions: Strategic GenAI mapping

Simply complete the form
to access your free white paper.

Work Email Address*

Role

Country*

Yes, I would like to be contacted by an IQVIA expert

I have read and agree to the below privacy policies

By ticking this box, you agree to receive emails from Citeline, and carefully selected partners

Lead Source - PI Partner

Primary Product Interest*

You agree Citeline and IQVIA may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and IQVIA.

Optimizing Generative AI in Clinical Operations through Focus, Restraint, and Maximized Validation

Considerations for the responsible use of generative AI to serve the interests of medical research and patient health

Simply complete the form to access your free white paper.

Simply complete the form
to access your free white paper.